ACI’s European Drug Safety Summit 2018 will take place in London on 17^th & 18^th October. The two day event will bring together pharmacovigilance personnel from key pharmaceutical companies and will address the challenges in monitoring and maintaining drug safety strategies. The event will also discuss how to apply new technologies and strategic approaches to effectively manage drug safety and will discover key developments in the handling, analysis and reporting of adverse events during trials and understand the regulators requirements with the aim of speeding drugs to market whilst mitigating the risk of recall.

Key Topics Include:

• Meeting Safety Requirement: Regulator’s Perspective
• Building a Pharmacovigilance Strategy
• Evolving PV Strategies for Tomorrow
• Technological Advancement in Pharmacovigilance
• Clinical Data Management
• The Role of Big Data and Social Media in PV
• Ensure Drug Safety & Risk Minimisation Measures
• Latest Development & Innovation Approach for Effective Signal Management
• Development of Qualified Personal Responsible for Pharmacovigilance (QPPV)
• Pharmacovigilance for Advanced Therapies

Who Will Attend?

Attendees will be drawn primarily from pharmaceutical, biotechnology and contract research organisations and include VPs, Directors and Managers/Scientists working in Drug Safety, Pharmacovigilance, Epidemiology, Clinical Research and Development, Clinical Trial Management, Pharmacology, Regulatory Affairs and Compliance, Strategy and Business Development, Risk Management, QPPV.